FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RemedyRepack Rifampin Capsules Recall

Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore…

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
Jan 18, 2023
Recall ID
D-0098-2023
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Rifampin Capsules starting Dec 20, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0098-2023 on Jan 18, 2023. Reason: Failed Impurities/Degradation specifications. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation specifications

Product description

Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, Repackaged NDC 70518-2404-00.

Lot numbers, UPCs & expiration codes

Lot #: J0599794-022322, exp. date 02/28/2023; J0621369-052622, exp. date 06/30/2023

Where it was sold

Product was distributed to one account in PA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0098-2023
Classification
Class II
Status
Terminated
Recall initiated
Dec 20, 2022
FDA report date
Jan 18, 2023
Quantity
132 Cards of 30 = 3960 Tablets
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-0098-2023, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
91345
Address
625 Kolter Dr Ste 4
Code information
Lot #: J0599794-022322, exp. date 02/28/2023; J0621369-052622, exp. date 06/30/2023
Postal code
15701-3571
Report date
Jan 18, 2023
Product type
Drugs
Recall number
D-0098-2023
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
132 Cards of 30 = 3960 Tablets
Termination date
Mar 3, 2023
Reason for recall
Failed Impurities/Degradation specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, Repackaged NDC 70518-2404-00.
Distribution pattern
Product was distributed to one account in PA.
Recall initiation date
Dec 20, 2022
Initial firm notification
Letter
Center classification date
Jan 6, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0098-2023, published Jan 18, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls